‘Jawbone Death’ and the Law: The Latest Fosamax Trial Rolls On
The condition, a debilitating jaw deterioration, has taken center stage in a trial in Manhattan over Merck’s drug Fosamax, which thousands have alleged causes the condition.
The condition, a debilitating jaw deterioration, has taken center stage in a trial in Manhattan over Merck’s drug Fosamax, which thousands have alleged causes the condition. Fosamax is most typically prescribed to older women with thinning bones.
The case is pitting Judith Graves, a 67-year-old retired investigator for the United States Army, against Merck. According to the NYT, her lawyer, Timothy O’Brien recently told the jury that Graves’s jaw deterioration, allegedly caused by Fosamax, had required five surgeries, including one to replace part of her jaw with a bone from her left arm.
In a Feb. 1 settlement, German automaker Volkswagen agreed to fully compensate American consumers who purchased 3.0-liter diesel engine vehicles equipped with the company’s rigged “clean diesel” emissions testing devices. The company [...]February 3, 2017 By: Seeger Weiss read more
On January 24, U.S. District Court Judge Brian R. Martinotti appointed Christopher A. Seeger to act as Co-Lead Counsel of the Plaintiffs’ Steering Committee in the Invokana multidistrict litigation [...]January 25, 2017 By: Seeger Weiss read more